RZLT · Categories · Form 4

RZLT - SEC Form 4 insider transactions

Rezolute Inc. (RZLT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RZLT

• 32d
  SEC Form 4 filed by Evans Daron

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  Chief Medical Officer Roberts Brian Kenneth covered exercise/tax liability with 11,439 shares, decreasing direct ownership by 4% to 296,913 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  CFO Evans Daron covered exercise/tax liability with 11,438 shares, decreasing direct ownership by 3% to 404,462 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  CEO Elam Nevan C covered exercise/tax liability with 27,618 shares, decreasing direct ownership by 4% to 613,501 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Chief Medical Officer Roberts Brian Kenneth was granted 123,000 shares, increasing direct ownership by 78% to 280,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Chief Commercial Officer Karnawat Sunil Ratilal was granted 32,000 shares, increasing direct ownership by 117% to 59,442 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  CEO Elam Nevan C was granted 317,000 shares, increasing direct ownership by 109% to 609,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  CFO Evans Daron was granted 107,000 shares, increasing direct ownership by 40% to 375,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Kreher Nerissa was granted 21,000 shares, increasing direct ownership by 56% to 58,576 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Hogenhuis Wladimir was granted 21,000 shares, increasing direct ownership by 23% to 114,025 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Harris Erik was granted 21,000 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Kim Young-Jin was granted 21,000 shares, increasing direct ownership by 14% to 170,950 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Fauchet Philippe was granted 21,000 shares, increasing direct ownership by 61% to 55,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Labrucherie Gil M was granted 21,000 shares, increasing direct ownership by 61% to 55,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 248d
  Chief Commercial Officer Karnawat Sunil Ratilal was granted 25,000 shares, increasing direct ownership by 1,024% to 27,442 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Kreher Nerissa was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Labrucherie Gil M was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Hogenhuis Wladimir was granted 9,000 shares, increasing direct ownership by 11% to 93,025 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Director Kim Young-Jin was granted 9,000 shares, increasing direct ownership by 6% to 149,950 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  CFO Evans Daron was granted 26,000 shares, increasing direct ownership by 11% to 263,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Director Fauchet Philippe was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Chief Medical Officer Roberts Brian Kenneth was granted 26,000 shares, increasing direct ownership by 20% to 157,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  CEO Elam Nevan C was granted 68,000 shares, increasing direct ownership by 30% to 292,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 402d
  SEC Form 4 filed by Director Harris Erik

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 436d
  Director Labrucherie Gil M was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  CFO Evans Daron was granted 77,000 shares, increasing direct ownership by 51% to 227,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Director Kreher Nerissa was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Chief Medical Officer Roberts Brian Kenneth was granted 77,000 shares, increasing direct ownership by 142% to 131,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  CEO Elam Nevan C was granted 204,000 shares, increasing direct ownership by 2,610% to 211,817 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Director Fauchet Philippe was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 585d
  SEC Form 4 filed by CFO Evans Daron

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Evans Daron

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Roberts Brian Kenneth

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Elam Nevan C

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Hogenhuis Wladimir

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Labrucherie Gil M

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Fauchet Philippe

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 828d
  SEC Form 4 filed by Kreher Nerissa

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1031d
  SEC Form 4 filed by Roberts Brian Kenneth

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1404d
  SEC Form 4 filed by Kim Young-Jin

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Fauchet Philippe

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Roberts Brian Kenneth

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Hogenhuis Wladimir

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Elam Nevan C

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Labrucherie Gil M

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1405d
  SEC Form 4 filed by Kreher Nerissa

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1444d
  SEC Form 4: Roberts Brian Kenneth bought $4,862 worth of shares (1,500 units at $3.24), increasing direct ownership by 7% to 22,552 units

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1454d
  SEC Form 4: Labrucherie Gil M bought $199,998 worth of shares (52,631 units at $3.80) (Amendment)

  4/A - Rezolute, Inc. (0001509261) (Issuer)
• 1457d
  SEC Form 4: Roberts Brian Kenneth bought $79,998 worth of shares (21,052 units at $3.80)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1457d
  SEC Form 4: Labrucherie Gil M bought $199,998 worth of shares (52,631 units at $3.80)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1457d
  SEC Form 4: Hogenhuis Wladimir bought $145,004 worth of shares (32,693 units at $4.44)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1705d
  SEC Form 4 filed by Elam Nevan C (Amendment)

  4/A - Rezolute, Inc. (0001509261) (Issuer)
• 1739d
  SEC Form 4: Genexine Inc. converted options into 56,818,175 units of Common Stock and bought $10,000,000 worth of Common Stock (34,482,758 units at $0.29)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by Hogenhuis Wladimir

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by FAUCHET PHILIPPE

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by Labrucherie Gil M

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by KREHER NERISSA

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by ROBERTS BRIAN KENNETH

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 1753d
  SEC Form 4 filed by Elam Nevan C

  4 - Rezolute, Inc. (0001509261) (Issuer)

Other RZLT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends